Trials / Completed
CompletedNCT00832455
Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)
A 12 Week Multicenter, Open-label, Observational Study to Evaluate the Effectiveness of Montelukast Sodium (Singulair®), 4 or 5 mg/Day in Pediatric Subjects With Uncontrolled Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 445 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
a study to describe patient and physician satisfaction with montelukast therapy for the control of asthma used either as monotherapy or in combination with inhaled corticosteroids
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Montelukast 4-5 mg for 12 weeks, oral tablet |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2009-01-30
- Last updated
- 2024-05-13
- Results posted
- 2010-02-05
Source: ClinicalTrials.gov record NCT00832455. Inclusion in this directory is not an endorsement.